FOXO Technologies Inc. (FOXO)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 0 | 1 | 0 | 4 | 16 | 18 | - |
| Operating profit | $m | -10 | - | ||||||
| Net profit | $m | -9 | -38 | -95 | -26 | -12 | -12 | -5 | - |
| EPS reported | $ | -0.13 | -0.21 | ||||||
| Operating cashflow per share | $ | -0.01 | -0.00 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | -0.01 | -0.00 | ||||||
| Free cash flow | $m | -4 | 0 | ||||||
| Net debt | $m | 8 | 18 | ||||||
| Book value equity | $m | 11 | - | ||||||
| Book value per share | $ | 0.04 | 0.00 | ||||||
| Number of shares | m | 264.78 | 96.97 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 7.13 | 9.68 | ||||||
| P/S LTM | x | 4.85 | 4.45 | ||||||
| P/FCF LTM | x | -20.23 | 380.62 | ||||||
| EV/EBITDA LTM | x | -10.49 | -191.79 | ||||||
| EV/Sales LTM | x | 5.51 | 0.68 | ||||||
| Earnings Yield LTM | % | -15.65% | -14.11% | ||||||
| FCF Yield | % | -4.94% | +0.26% | ||||||
| Quality | |||||||||
| ROE | % | -111.53% | -96.85% | ||||||
| ROIC | % | -42.88% | -38.21% | ||||||
| Operating margin | % | -63.11% | -49.33% | ||||||
| Gross margin | % | +49.12% | +51.22% | ||||||
| FCF/Sales | % | -23.99% | -13.46% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +303.98% | +340.87% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.36 | 0.01 | ||||||
| Net Debt/EBITDA | x | -1.25 | -1.28 | ||||||
| EBIT/Net interest | x | 3.01 | -24.58 | ||||||
| Net debt/market cap | % | +9.81% | +30.29% | ||||||
| Net debt/Equity | x | 0.68 | - | ||||||
| Gross debt/equity | x | 0.98 | - | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free